Fingolimod induced fulminant liver failure requiring liver transplantation: A case report.

IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Hepatology Forum Pub Date : 2023-03-01 DOI:10.14744/hf.2022.2022.0033
Ali Riza Caliskan, Muhsin Murat Muhip Harputluoglu, Emine Samdanci, Salih Cirik, Sezai Yilmaz
{"title":"Fingolimod induced fulminant liver failure requiring liver transplantation: A case report.","authors":"Ali Riza Caliskan,&nbsp;Muhsin Murat Muhip Harputluoglu,&nbsp;Emine Samdanci,&nbsp;Salih Cirik,&nbsp;Sezai Yilmaz","doi":"10.14744/hf.2022.2022.0033","DOIUrl":null,"url":null,"abstract":"<p><p>Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 - year - old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis.</p>","PeriodicalId":29722,"journal":{"name":"Hepatology Forum","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0c/2d/hf-4-074.PMC10209975.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hepatology Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/hf.2022.2022.0033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Fingolimod has been used for about ten years to treat multiple recurrent sclerosis. It has been reported that Fingolimod causes an elevation in liver enzymes. In this case report, the clinical and laboratory parameters improved after discontinuation of the drug. However, there is no publication in the literature regarding acute liver failure and liver transplantation following Fingolimod treatment. In this article, we presented a 33 - year - old female patient who developed acute liver failure and underwent liver transplantation after Fingolimod treatment for recurrent multiple sclerosis.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
芬戈莫德致暴发性肝衰竭需要肝移植1例报告。
芬戈莫德用于治疗多发性复发性硬化症已有十年之久。据报道,芬戈莫德引起肝酶升高。在本病例报告中,临床和实验室参数在停药后有所改善。然而,文献中没有关于芬戈莫治疗后急性肝衰竭和肝移植的出版物。在这篇文章中,我们报告了一位33岁的女性患者,她因复发性多发性硬化症接受芬戈莫德治疗后出现急性肝衰竭并接受肝移植。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.90
自引率
12.50%
发文量
0
期刊最新文献
Safety analysis of different ıntensities of elf-pemf in terms of apoptotic, inflammatory, and transcription factor NF-Κb expression levels in rat liver. An alternative method in the diagnosis of intrabiliary lesions: Percutaneous endobiliary brush biopsy. D-dimer is a prognostic marker for 1-year mortality in patients with chronic liver failure and hepatic encephalopathy. Intrabiliary pressure in the pathophysiology of extra hepatic biliary obstruction. Leflunomide induced fatal dress syndrome need liver transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1